Abstract
6017Background: Patients (pts) with treatment-refractory salivary gland cancer have limited treatment options. The PD-1 pathway is upregulated in many tumors leading to immune response suppression....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have